tradingkey.logo
搜索

Bioharvest Sciences Inc

BHST
添加自选
2.910USD
+0.050+1.75%
收盘 07/01, 16:00美东报价延迟15分钟
64.98M总市值
亏损市盈率 TTM

Bioharvest Sciences Inc

2.910
+0.050+1.75%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.75%

5天

0.00%

1月

-21.35%

6月

-43.93%

今年开始到现在

-43.93%

1年

-57.62%

关键数据
2.910今开
2.975最高
61.49K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.27%换手率
2.860昨收
2.900最低
177.47K成交额
亏损市盈率静
2.87市净率
0.00%股息率 TTM
-31.71%ROA
12.30052周最高
1.83量比
-12.91M净利润
22.67M总股本
-0.5864每股收益TTM
-8.58Beta
-103.29%ROE
3.16052周最低
2.62%振幅
59.21%毛利率
64.98M总市值
-4.52回报/风险
4.64%风险率

TradingKey Bioharvest Sciences Inc股票评分

单位: USD 更新时间: 2026-07-01

操作建议

Bioharvest Sciences Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在食品与烟草行业排名48/93位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价12.75。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bioharvest Sciences Inc评分

相关信息

行业排名
48 / 93
全市场排名
240 / 4564
所属行业
食品与烟草

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Bioharvest Sciences Inc亮点

亮点风险
BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
业绩高增长
公司营业收入稳步增长,连续3年增长172.32%
业绩增长期
公司处于发展阶段,最新年度总收入34.51M美元
估值高估
公司最新PE估值-4.96,处于3年历史高位
机构加仓
最新机构持股1.80M股,环比增加47.82%

分析师目标

根据 4 位分析师
买入
评级
12.750
目标均价
+345.80%
涨幅空间

Bioharvest Sciences Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bioharvest Sciences Inc简介

BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
公司代码BHST
公司Bioharvest Sciences Inc
CEOSobel (Ilan)
网址https://bioharvest.com/about/

常见问题

Bioharvest Sciences Inc(BHST)的当前股价是多少?

Bioharvest Sciences Inc(BHST)的当前股价是 2.91。

Bioharvest Sciences Inc的股票代码是什么?

Bioharvest Sciences Inc的股票代码是BHST。

Bioharvest Sciences Inc股票的52周最高点是多少?

Bioharvest Sciences Inc股票的52周最高点是12.30。

Bioharvest Sciences Inc股票的52周最低点是多少?

Bioharvest Sciences Inc股票的52周最低点是3.16。

Bioharvest Sciences Inc的市值是多少?

Bioharvest Sciences Inc的市值是65.96M。

现在Bioharvest Sciences Inc(BHST)的股票是买入、持有还是卖出?

根据分析师评级,Bioharvest Sciences Inc(BHST)的总体评级为买入,目标价格为12.75。

Bioharvest Sciences Inc(BHST)股票的每股收益(EPS TTM)是多少

Bioharvest Sciences Inc(BHST)股票的每股收益(EPS TTM)是-0.60。